Dominic Arthur Jaeger, MD - Medicare Internal Medicine in Brandon, MS

Dominic Arthur Jaeger, MD is a medicare enrolled "Internal Medicine" physician in Brandon, Mississippi. He went to University Of North Carolina At Chapel Hill School Of Medicine and graduated in 1990 and has 34 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice St. Dominic Medical Associates Llc, Mississippi Hma Hospitalists Llc and his current practice location is 350 Crossgates Blvd, Brandon, Mississippi. You can reach out to his office (for appointments etc.) via phone at (601) 664-1361.

Dominic Arthur Jaeger is licensed to practice in Mississippi (license number 18275) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1841361938.

Contact Information

Dominic Arthur Jaeger, MD
350 Crossgates Blvd,
Brandon, MS 39042-2601
(601) 664-1361
Not Available



Physician's Profile

Full NameDominic Arthur Jaeger
GenderMale
SpecialityInternal Medicine
Experience34 Years
Location350 Crossgates Blvd, Brandon, Mississippi
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dominic Arthur Jaeger attended and graduated from University Of North Carolina At Chapel Hill School Of Medicine in 1990
  NPI Data:
  • NPI Number: 1841361938
  • Provider Enumeration Date: 11/13/2006
  • Last Update Date: 01/09/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 5193611069
  • Enrollment ID: I20040226000582

Medical Identifiers

Medical identifiers for Dominic Arthur Jaeger such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1841361938NPI-NPPES
03281556MedicaidMS
P01184541OtherMSRR MEDICARE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 18275 (Mississippi)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Gentiva HospiceFlowood, MSHospice
Crossgates River Oaks HospitalBrandon, MSHospital
St Dominic-jackson Memorial HospitalJackson, MSHospital
Merit Health River OaksFlowood, MSHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
St. Dominic Medical Associates Llc0446303168154
Mississippi Hma Hospitalists Llc599197207716

News Archive

Global Health Partner AB's fourth-quarter revenues increase 13%

2009 was an eventful year, with a mixture of successes and breakthroughs, but also with some challenges which required that measures be taken during the autumn. Our mature clinics continued to develop well during the year, as did most of our newly started clinics. 2009 was therefore the first time that we achieved a positive whole-year result before close-down costs in England, despite increasing development and start-up costs for the Group as a whole.

MMV supports Pfizer's AZCQ clinical trial for intermittent preventive treatment of malaria in pregnant women

Pfizer Inc. and Medicines for Malaria Venture (MMV) entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp). There is currently an unmet need for new treatment options and the World Health Organization (WHO) estimates that some 30 million pregnant women are at risk for malaria in endemic areas in Africa each year.

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dominic Arthur Jaeger allows following entities to bill medicare on his behalf.
Entity NameState Of Mississippi - University Of Mississippi Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154317527
PECOS PAC ID: 1850293036
Enrollment ID: O20090414000575

News Archive

Global Health Partner AB's fourth-quarter revenues increase 13%

2009 was an eventful year, with a mixture of successes and breakthroughs, but also with some challenges which required that measures be taken during the autumn. Our mature clinics continued to develop well during the year, as did most of our newly started clinics. 2009 was therefore the first time that we achieved a positive whole-year result before close-down costs in England, despite increasing development and start-up costs for the Group as a whole.

MMV supports Pfizer's AZCQ clinical trial for intermittent preventive treatment of malaria in pregnant women

Pfizer Inc. and Medicines for Malaria Venture (MMV) entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp). There is currently an unmet need for new treatment options and the World Health Organization (WHO) estimates that some 30 million pregnant women are at risk for malaria in endemic areas in Africa each year.

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

Read more Medical News

› Verified 7 days ago

Entity NameSt. Dominic Medical Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407920549
PECOS PAC ID: 0446303168
Enrollment ID: O20090728000821

News Archive

Global Health Partner AB's fourth-quarter revenues increase 13%

2009 was an eventful year, with a mixture of successes and breakthroughs, but also with some challenges which required that measures be taken during the autumn. Our mature clinics continued to develop well during the year, as did most of our newly started clinics. 2009 was therefore the first time that we achieved a positive whole-year result before close-down costs in England, despite increasing development and start-up costs for the Group as a whole.

MMV supports Pfizer's AZCQ clinical trial for intermittent preventive treatment of malaria in pregnant women

Pfizer Inc. and Medicines for Malaria Venture (MMV) entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp). There is currently an unmet need for new treatment options and the World Health Organization (WHO) estimates that some 30 million pregnant women are at risk for malaria in endemic areas in Africa each year.

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

Read more Medical News

› Verified 7 days ago

Entity NameMississippi Hma Hospitalists Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154608883
PECOS PAC ID: 5991972077
Enrollment ID: O20120112000182

News Archive

Global Health Partner AB's fourth-quarter revenues increase 13%

2009 was an eventful year, with a mixture of successes and breakthroughs, but also with some challenges which required that measures be taken during the autumn. Our mature clinics continued to develop well during the year, as did most of our newly started clinics. 2009 was therefore the first time that we achieved a positive whole-year result before close-down costs in England, despite increasing development and start-up costs for the Group as a whole.

MMV supports Pfizer's AZCQ clinical trial for intermittent preventive treatment of malaria in pregnant women

Pfizer Inc. and Medicines for Malaria Venture (MMV) entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp). There is currently an unmet need for new treatment options and the World Health Organization (WHO) estimates that some 30 million pregnant women are at risk for malaria in endemic areas in Africa each year.

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

Read more Medical News

› Verified 7 days ago

Entity NameSt. Dominic Hospital Medicine Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104362292
PECOS PAC ID: 5597034348
Enrollment ID: O20170711000091

News Archive

Global Health Partner AB's fourth-quarter revenues increase 13%

2009 was an eventful year, with a mixture of successes and breakthroughs, but also with some challenges which required that measures be taken during the autumn. Our mature clinics continued to develop well during the year, as did most of our newly started clinics. 2009 was therefore the first time that we achieved a positive whole-year result before close-down costs in England, despite increasing development and start-up costs for the Group as a whole.

MMV supports Pfizer's AZCQ clinical trial for intermittent preventive treatment of malaria in pregnant women

Pfizer Inc. and Medicines for Malaria Venture (MMV) entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp). There is currently an unmet need for new treatment options and the World Health Organization (WHO) estimates that some 30 million pregnant women are at risk for malaria in endemic areas in Africa each year.

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dominic Arthur Jaeger is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dominic Arthur Jaeger, MD
350 Crossgates Blvd,
Brandon, MS 39042-2601

Ph: (601) 644-1361
Dominic Arthur Jaeger, MD
350 Crossgates Blvd,
Brandon, MS 39042-2601

Ph: (601) 664-1361

News Archive

Global Health Partner AB's fourth-quarter revenues increase 13%

2009 was an eventful year, with a mixture of successes and breakthroughs, but also with some challenges which required that measures be taken during the autumn. Our mature clinics continued to develop well during the year, as did most of our newly started clinics. 2009 was therefore the first time that we achieved a positive whole-year result before close-down costs in England, despite increasing development and start-up costs for the Group as a whole.

MMV supports Pfizer's AZCQ clinical trial for intermittent preventive treatment of malaria in pregnant women

Pfizer Inc. and Medicines for Malaria Venture (MMV) entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp). There is currently an unmet need for new treatment options and the World Health Organization (WHO) estimates that some 30 million pregnant women are at risk for malaria in endemic areas in Africa each year.

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

Two awards to advance pancreatic cancer research

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Stephanie K. Dougan, Ph.D., postdoctoral fellow at the Whitehead Institute for Biomedical Research, and Oliver G. McDonald, M.D., Ph.D., postdoctoral fellow at Johns Hopkins University, the 2012 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants.

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

Read more News

› Verified 7 days ago


Internal Medicine Doctors in Brandon, MS

George B Schimmel, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 346 Crossgates Blvd, Suite 203, Brandon, MS 39042
Phone: 601-825-2424    Fax: 601-825-7621
Dr. Corey Nathaniel Brown, DO
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 350 Crossgates Blvd, Brandon, MS 39042
Phone: 662-545-7300    
Dr. Lloyd James Gordon Iii, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 3949 Highway 43 N, Brandon, MS 39047
Phone: 601-829-2500    
Dr. Shuja Yousuf, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 348 Crossgates Blvd Ste 1300, Brandon, MS 39042
Phone: 601-825-5000    
Nusrat J Khansur, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1551 W Government St, Brandon, MS 39042
Phone: 601-825-3163    Fax: 601-825-7893

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.